2015 Strategic Assessments of Current and Emerging Cancer Diagnostics Market Players
This new report from VPGMarketResearch.com provides strategic assessments of major cancer diagnostic product suppliers and emerging market entrants. The report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Contains 80 pages
Contains 80 pages
Abbott
AdnaGen/Alere
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics
bioMerieux
Bio-Rad
CellSearch
Cepheid
Correlogic Systems/Vermill
AdnaGen/Alere
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics
bioMerieux
Bio-Rad
CellSearch
Cepheid
Correlogic Systems/Vermill
More Publications
2015 Strategic Assessments of Current and Emerging Blood Typing, Grouping and NAT Screening Market Players
US$ 2,800.00
July 2015
225 pages
2015 Strategic Assessments of Current and Emerging Blood Banking, Cancer Diagnostic, Coagulation, Hematology, Immunodiagnostic, Microbiology, and Molecular Diagnostic Instrument and Reagent Suppliers
US$ 6,800.00
July 2015
-
2015 Strategic Assessments of Current and Emerging Hemostasis Diagnostics Market Players
US$ 2,000.00
July 2015
45 pages
2015 Strategic Assessments of Current and Emerging Infectious Disease Diagnostics Market Players
US$ 1,960.00
July 2015
90 pages
2015 Strategic Assessments of Current and Emerging Hematology and Flow Cytometry Market Players
US$ 1,960.00
July 2015
30 pages
